PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 31 filers reported holding PDL BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $223,000 | +2.3% | 230,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $218,000 | +4.8% | 230,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $208,000 | +13.0% | 230,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $184,000 | -9.4% | 230,000 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $203,000 | -6.9% | 230,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $218,000 | -0.9% | 230,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $220,000 | 0.0% | 230,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $220,000 | – | 230,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|